Investors Don't See Light At End Of Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Tunnel And Push Stock Down 26%

Simply Wall StDec 20 03:15

Selling Amylyx Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall StDec 11 20:03

BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $10

Futu NewsDec 6 01:31 · Ratings

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $12

Futu NewsDec 6 01:31 · Ratings

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target

BenzingaDec 5 20:07 · Ratings

Express News | Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug

BreakingsDec 4 22:50